MD20190018A2 - Compoziţie, în particular o compoziţie farmaceutică preventivă şi curativă pe bază de peroxometalat - Google Patents

Compoziţie, în particular o compoziţie farmaceutică preventivă şi curativă pe bază de peroxometalat

Info

Publication number
MD20190018A2
MD20190018A2 MDA20190018A MD20190018A MD20190018A2 MD 20190018 A2 MD20190018 A2 MD 20190018A2 MD A20190018 A MDA20190018 A MD A20190018A MD 20190018 A MD20190018 A MD 20190018A MD 20190018 A2 MD20190018 A2 MD 20190018A2
Authority
MD
Moldova
Prior art keywords
composition
peroxometallate
preventive
mixture
pharmaceutical composition
Prior art date
Application number
MDA20190018A
Other languages
English (en)
Russian (ru)
Other versions
MD4898B1 (ro
Inventor
Реми ВИЛЬМОТТ
Фредерик ЛОРЕНЦО
Денис Оливье КРЕТЬЯН
Original Assignee
Oxymo Technologies Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxymo Technologies Inc. filed Critical Oxymo Technologies Inc.
Publication of MD20190018A2 publication Critical patent/MD20190018A2/ro
Publication of MD4898B1 publication Critical patent/MD4898B1/ro

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/242—Gold; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/244—Lanthanides; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Invenţia se referă la un amestec sau o compoziţie, de preferinţă terapeutic activă administrată topic, care conţine cel puţin o sare a unui metal, metalul fiind selectat dintre molibden (Mo), volfram (W), vanadiu (V), aur (Au), o lantanidă, în particular lantan; cel puţin un agent de chelare; cel puţin o sursă de radicali de peroxidare; cel puţin un agent tampon; precum şi la compoziţii farmaceutice, formate din acest amestec sau conţinându-l, metode de producere şi aplicare a acestuia, şi anume pentru o metodă de tratament terapeutic a unei infecţii virale, în particular implicând un virus din familia Herpesviridae,sau ca un antiinflamator.
MDA20190018A 2016-03-29 2017-03-29 Compoziţie, în particular o compoziţie farmaceutică preventivă şi curativă pe bază de peroxometalat MD4898B1 (ro)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1652697A FR3049465B1 (fr) 2016-03-29 2016-03-29 Composition pharmaceutique preventive et curative a base de peroxometallate
PCT/IB2017/051797 WO2017168344A1 (fr) 2016-03-29 2017-03-29 Composition, notamment composition pharmaceutique préventive et curative, à base de peroxométallate

Publications (2)

Publication Number Publication Date
MD20190018A2 true MD20190018A2 (ro) 2019-08-31
MD4898B1 MD4898B1 (ro) 2024-08-31

Family

ID=56119576

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20190018A MD4898B1 (ro) 2016-03-29 2017-03-29 Compoziţie, în particular o compoziţie farmaceutică preventivă şi curativă pe bază de peroxometalat

Country Status (23)

Country Link
US (3) US10857179B2 (ro)
EP (1) EP3435979B1 (ro)
JP (1) JP7516006B2 (ro)
KR (1) KR102345412B1 (ro)
CN (1) CN109562062A (ro)
AU (1) AU2017243946B2 (ro)
BR (1) BR112018069814A2 (ro)
CA (1) CA3019739A1 (ro)
CL (1) CL2018002717A1 (ro)
CO (1) CO2018011344A2 (ro)
EA (1) EA038115B1 (ro)
FR (1) FR3049465B1 (ro)
IL (1) IL261982B2 (ro)
MA (1) MA44950B1 (ro)
MD (1) MD4898B1 (ro)
MY (1) MY197527A (ro)
PE (1) PE20190259A1 (ro)
PH (1) PH12018502091A1 (ro)
SA (1) SA518400119B1 (ro)
SG (1) SG11201808651WA (ro)
TN (1) TN2018000332A1 (ro)
WO (1) WO2017168344A1 (ro)
ZA (2) ZA201806489B (ro)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8933078B2 (en) 2011-07-14 2015-01-13 Research Cancer Institute Of America Method of treating cancer with combinations of histone deacetylase inhibitors (HDAC1) substances
FR3049465B1 (fr) * 2016-03-29 2018-04-27 Oxymo Technologies Inc. Composition pharmaceutique preventive et curative a base de peroxometallate
US11890292B2 (en) 2017-02-27 2024-02-06 Research Cancer Institute Of America Compositions, methods, systems and/or kits for preventing and/or treating neoplasms
WO2018170457A1 (en) 2017-03-17 2018-09-20 Research Cancer Institute Of America Compositions, methods, systems and/or kits for preventing and/or treating neoplasms
FR3110396B1 (fr) 2020-05-20 2023-03-17 M G B Pharma Composition comprenant un composé ascorbo-camphorate métallique pour son utilisation dans le traitement des infections causées par herpèsvirus
WO2021262749A1 (en) * 2020-06-26 2021-12-30 Research Cancer Institute Of America Compositions and methods for preventing and/or treating viral infection
CN115246656B (zh) * 2022-01-12 2023-07-25 青岛大学 一种氧化钼/铁纳米材料的制备方法及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0629191B2 (ja) * 1984-09-04 1994-04-20 株式会社ポリトロニクス 抗腫瘍剤、抗ウィルス剤
JP2707252B2 (ja) * 1987-08-03 1998-01-28 利博 山瀬 抗ウィルス剤
JP3121859B2 (ja) * 1991-05-31 2001-01-09 利博 山瀬 抗ウイルス剤
JP4420997B2 (ja) * 1999-02-08 2010-02-24 利博 山瀬 抗ウィルス剤
FR2792500B1 (fr) 1999-04-23 2004-05-21 Internat Redox Dev Composition aqueuse, notamment sous forme de gel, a base de ho2f , acides et ions metalliques, procede de preparation notamment quand lesdits ions sont ag2+ et utilisation dans le domaine de la desinfection et/ou du traitement de surface
FR2858086A1 (fr) * 2003-07-23 2005-01-28 France Telecom Procede d'estimation de la pertinence d'un document par rapport a un concept
US7553805B2 (en) * 2005-02-25 2009-06-30 Solutions Biomed, Llc Methods and compositions for treating viral, fungal, and bacterial infections
FR2932952A1 (fr) * 2008-06-26 2010-01-01 Orbeco Inc Composition aqueuse, notamment desinfectante, a base de h202 procede de fabrication et utilisation.
CA2910212A1 (en) * 2013-04-25 2014-10-30 Cerion Enterprises, Llc Chelated nanoceria for the treatment of oxidative stress
FR3049465B1 (fr) * 2016-03-29 2018-04-27 Oxymo Technologies Inc. Composition pharmaceutique preventive et curative a base de peroxometallate

Also Published As

Publication number Publication date
WO2017168344A1 (fr) 2017-10-05
KR20190015208A (ko) 2019-02-13
EP3435979C0 (fr) 2023-06-14
KR102345412B1 (ko) 2021-12-29
US20190125791A1 (en) 2019-05-02
AU2017243946A1 (en) 2018-10-18
TN2018000332A1 (fr) 2020-01-16
EP3435979B1 (fr) 2023-06-14
US10857179B2 (en) 2020-12-08
FR3049465B1 (fr) 2018-04-27
IL261982A (en) 2018-10-31
MD4898B1 (ro) 2024-08-31
EA038115B1 (ru) 2021-07-08
JP7516006B2 (ja) 2024-07-16
US20230102115A1 (en) 2023-03-30
ZA201902008B (en) 2021-01-27
FR3049465A1 (fr) 2017-10-06
IL261982B (en) 2022-11-01
PE20190259A1 (es) 2019-02-25
SG11201808651WA (en) 2018-11-29
MA44950A1 (fr) 2019-11-29
EA201891941A1 (ru) 2019-04-30
IL261982B2 (en) 2023-03-01
CO2018011344A2 (es) 2019-02-08
US20210030788A1 (en) 2021-02-04
EP3435979A1 (fr) 2019-02-06
PH12018502091A1 (en) 2019-07-29
JP2019510773A (ja) 2019-04-18
AU2017243946B2 (en) 2022-09-08
CA3019739A1 (fr) 2017-10-05
ZA201806489B (en) 2019-08-28
US11944639B2 (en) 2024-04-02
BR112018069814A2 (pt) 2019-01-29
SA518400119B1 (ar) 2022-09-01
CL2018002717A1 (es) 2019-02-22
MY197527A (en) 2023-06-20
MA44950B1 (fr) 2020-06-30
CN109562062A (zh) 2019-04-02

Similar Documents

Publication Publication Date Title
MD20190018A2 (ro) Compoziţie, în particular o compoziţie farmaceutică preventivă şi curativă pe bază de peroxometalat
ZA202211060B (en) Anti-viral compounds and methods for administration thereof
MX2022000453A (es) Compuestos útiles para tratar infecciones por virus de influenza.
MX2021010145A (es) Derivados de amida utiles en el tratamiento de una infeccion por vhb o de enfermedades inducidas por vhb.
CR20230100A (es) Compuestos fosfolípidos y usos de los mismos
MX2023004188A (es) Compuestos fosfolipidos y usos de estos.
CR20240223A (es) Compuestos terapéuticos para la infección por el virus del vih
TR201908007T4 (tr) Hıv enfeksiyonlarının tedavi edilmesine yönelik farmasötik bileşim.
MX2023008004A (es) Derivado de adenosina y composicion farmaceutica que lo comprende.
MX2020008360A (es) Forma cristalina de bictegravir sodico.
MX2023011546A (es) Composiciones nasales que comprenden alcaftadina.
MX2022009871A (es) Compuestos tetraciclicos para tratar la infeccion por el virus de la inmunodeficiencia humana (vih).
MX2022000433A (es) Proteinas de fusion a toxina para el tratamiento de enfermedades relacionadas con infecciones por cmv.
WO2019155360A3 (en) Pharmaceutical composition for treating bacterial and viral infections
MX2021015441A (es) Formas cristalinas de cabotegravir de sodio.
MX2024000472A (es) Composicion farmaceutica de virus no encapsulado.
MX2024002472A (es) Cocristales.
WO2016025010A8 (en) A novel broad-spectrum antiviral synergistic pharmaceutical composition for the treatment and prevention of viral infections
WO2022214678A3 (en) Human metapneumo virus vaccine
ZA202202243B (en) Aqueous pharmaceutical composition of anti-pd1 antibody prolgolimab and the use thereof
MX2018013475A (es) Acido carboxilico para tratar/prevenir congestion nasal.
EA201890789A1 (ru) Содержащая цинеол композиция для лечения заболеваний носа
MX2022012001A (es) Tratamiento preventivo de la migra?a.
WO2023230348A3 (en) Dosage regimens for treatment of dengue infection
ZA202210027B (en) Compositions of vitamin a palmitate, processes for their preparation, uses and methods comprising them